Advertisement

Response to Searle's Letter to the Editor

      We appreciate the interesting letter from Dr Searle. As he correctly pointed out, Bouhassira et al mentioned the Douleur Neuropathique 4 (DN4) questionnaire in relation to risk factors for the development of postherpetic neuralgia.
      • Bouhassira D.
      • Chassany O.
      • Gaillat J.
      • Hanslik T.
      • Launay O.
      • Mann C.
      • Rabaud C.
      • Rogeaux O.
      • Strady C.
      Patient perspective on herpes zoster and its complications: An observational prospective study in patients aged over 50 years in general practice.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The Journal of Pain
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Bouhassira D.
        • Chassany O.
        • Gaillat J.
        • Hanslik T.
        • Launay O.
        • Mann C.
        • Rabaud C.
        • Rogeaux O.
        • Strady C.
        Patient perspective on herpes zoster and its complications: An observational prospective study in patients aged over 50 years in general practice.
        Pain. 2012; 153: 342-349
        • Cho S.I.
        • Lee C.H.
        • Park G.H.
        • Park C.W.
        • Kim H.O.
        Use of S-LANSS, a tool for screening neuropathic pain, for predicting postherpetic neuralgia in patients after acute herpes zoster events: A single-center, 12-month, prospective cohort study.
        J Pain. 2013; 15: 149-156

      Linked Article

      • The Predictive Qualities of Neuropathic Screening Tools
        The Journal of PainVol. 15Issue 7
        • Preview
          I read with interest the article by Cho and colleagues reporting the predictive qualities of the S-LANSS (Self-completed Leeds Assessment of Neuropathic Symptoms and Signs) neuropathic pain screening tool when used in patients with acute herpes zoster.2 The authors report that no prior study has used screening tools in acute herpes zoster patients with the aim of predicting the development of postherpetic neuralgia. However, a DN4 (Douleur Neuropathique 4) screening tool diagnosis of neuropathic pain made during the first 7 days of herpes zoster infection has also been shown to be an independent predictor for the development of postherpetic neuralgia.
        • Full-Text
        • PDF